PROGNOSTIC SIGNIFICANCE OF FLT3/ITD MUTATION AND ABCB1 GENE POLYMORPHISMS IN CORE BINDING FACTOR (CBF)-ACUTE MYELOID LEUKEMIA (AML)

被引:0
|
作者
Kim, Y. K. [1 ]
Kim, H. N. [2 ]
Lee, I. K. [2 ]
Bang, S. M. [3 ]
Kim, H. J. [1 ,4 ]
Jo, D. Y. [5 ]
Won, J. H. [6 ]
Kwak, J. Y. [7 ]
Park, M. R. [8 ]
Ahn, J. S. [1 ]
Yang, D. H. [1 ]
Lee, J. J. [1 ]
Kim, H. J. [1 ,4 ]
机构
[1] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Genome Res Ctr Hematopoiet Ds, Jeollanam Do, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
[4] Catholic Univ Korea, Coll Med, Seoul, South Korea
[5] Chungnam Natl Univ, Coll Med, Chungju, South Korea
[6] Soonchunhyang Univ, Coll Med, Seoul, South Korea
[7] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea
[8] Wonkwang Univ, Sch Med, Iksan, South Korea
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0306
引用
收藏
页码:120 / 121
页数:2
相关论文
共 50 条
  • [1] More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)
    Kusec, Rajko
    Jaksic, Ozren
    Ostojic, Slobodanka
    Kardum-Skelin, Ika
    Vrhovac, Radovan
    Jaksic, Branimir
    BLOOD, 2006, 108 (01) : 405 - 406
  • [2] Prognostic significance of FLT3/ITD mutation in AML1/ETO-associated acute myeloid leukemia
    Kim, Yeo-Kyeoung
    Kim, Hee-Nam
    Lee, Il-Kwon
    Bang, Soo-Mee
    Jo, Deog-Yeon
    Won, Jong-Ho
    Yim, Chang-Yeol
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    BLOOD, 2007, 110 (11) : 1023A - 1023A
  • [3] Prognostic significance of FLT3/ITD mutation in patients with AML1/ETO associated acute myeloid leukemia
    Kim, Y.-K.
    Kim, H. N.
    Lee, I. K.
    Jo, D. Y.
    Won, J. H.
    Choi, J. H.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    Park, H. S.
    Kim, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 21 - 21
  • [4] Clinical significance of FLT3/ITD and NPM1 mutation in acute myeloid leukemia (AML).
    Suzuki, Rikio
    Onizuka, Makoto
    Shimada, Masako
    Iwaki, Yasunobu
    Kawada, Hiroshi
    Ogawa, Yoshiaki
    Hotta, Tomomitsu
    Ando, Kiyoshi
    BLOOD, 2006, 108 (11) : 188B - 188B
  • [5] Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
    Boissel, N.
    Leroy, H.
    Brethon, B.
    Philippe, N.
    de Botton, S.
    Auvrignon, A.
    Raffoux, E.
    Leblanc, T.
    Thomas, X.
    Hermine, O.
    Quesnel, B.
    Baruchel, A.
    Leverger, G.
    Dombret, H.
    Preudhomme, C.
    LEUKEMIA, 2006, 20 (06) : 965 - 970
  • [6] Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
    N Boissel
    H Leroy
    B Brethon
    N Philippe
    S de Botton
    A Auvrignon
    E Raffoux
    T Leblanc
    X Thomas
    O Hermine
    B Quesnel
    A Baruchel
    G Leverger
    H Dombret
    C Preudhomme
    Leukemia, 2006, 20 : 965 - 970
  • [7] Prognostic significance of mutations of nucleophosmin (NPM1) gene and internal tandem duplication of FLT3 gene (FLT3 ITD) in acute myeloid leukemia (AML) with normal karyotype
    Brunet, S.
    Esteve, J.
    Nomdedeu, J.
    Ribera, J. M.
    Llorente, A.
    Duarte, R.
    Tormo, M.
    Guardia, R.
    Montserrat, E.
    Sierra, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] AML, acute myeloid leukemia, FLT3 gene mutation Specific Features of the FLT3+Acute Myeloid Leukemia Course
    Radzhabova, Asiyat M.
    Martynkevich, Irina S.
    Motyko, Ekaterina V.
    Polushkina, Lubov B.
    Bakay, Marina P.
    Kuzyaeva, Anastasiya A.
    Voloshin, Sergey V.
    Potihonova, Nadezhda
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S228 - S229
  • [9] Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia
    Li, Chenglong
    Zhu, Biao
    Chen, Jiao
    Huang, Xiaobing
    MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 89 - 94
  • [10] Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation
    Carlos Best-Aguilera
    O. Rodrigo Gómez-Vázquez
    A. Elizabeth Guzmán-Hernández
    R. Monserrat Rojas-Sotelo
    Current Oncology Reports, 2017, 19